NL-OMON42376
Completed
Not Applicable
The innate immune system in atherosclerosis - II - ISA-II
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- arterial wall thickening
- Sponsor
- Academisch Medisch Centrum
- Enrollment
- 340
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\- aged 18 years or older
- •\- diagnosis of a known lipid disorder (including but not limited to hypercholestoremia, hypertriglyceridemia, combined hyperlipidemia, hypoalphalipoprotenemia, hypobetalipoprotenemia);Control group:
- •\- Age \>18 years
- •\- No previous cardiovascular events
- •\- No medication use
Exclusion Criteria
- •Both groups:
- •\- Known malignant disorders or any clinically significant medical condition that could interfere with the conduct of the study in the opinion of the investigator.
- •\- Inability or unwillingness to comply with the protocol requirements, or deemed by investigator to be unfit for the study.
- •\- History of cardiovascular event within the last 3 months
- •\- Clinical signs of acute infection
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The Innate Immune System in Atherosclerosisarterial wall thickeningatherosclerosis100126531000381610003216NL-OMON40196Academisch Medisch Centrum240
Recruiting
Not Applicable
Atherosclerosis and the Innate immune system in patients with Diabetesarterial wall thickeningatherosclerosis1001842410003216NL-OMON44284Academisch Medisch Centrum640
Active, not recruiting
Not Applicable
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular DiseasesSystemic Lupus ErythematosusNCT04276701University Hospital, Bordeaux500
Not yet recruiting
Not Applicable
Innate immunity and vascular complications in type II diabetic South-Asian immigrantscardiovascular diseasediabetesnephropathyretinopathy100110821004706010029149NL-OMON30311Academisch Medisch Centrum169
Unknown
Not Applicable
Investigating Atherosclerosis In Seronegative SpondyloarthropathyIn Seronegative SpondyloarthropathyNCT04891783Sohag University120